Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2677 |
|
| Actual shortage: | 255 (10%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2413 (90%) | |
Discontinuation Reports |
250 |
|
| To be discontinued: | 3 (1%) | |
| Discontinued: | 247 (99%) | |
| Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
30 (12%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2018-09-12 | 2019-01-31 | 61346 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2018-12-04 | 2019-08-06 | 68608 |
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86945 |
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2019-06-18 | 2019-08-06 | 86948 |
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Resolved | 2019-08-22 | 2019-10-24 | 92180 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2019-10-03 | 2019-10-10 | 95373 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2019-10-03 | 2019-10-10 | 95378 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2019-10-03 | 2019-11-01 | 95381 |
| ACT ENALAPRIL | 2MG | TABLET | Resolved | 2019-10-31 | 2020-03-05 | 97602 |
| DOXORUBICIN HYDROCHLORIDE INJECTION | 2MG | SOLUTION | Resolved | 2020-01-09 | 2020-02-21 | 102893 |
| TEVA-TERAZOSIN | 2MG | TABLET | Actual shortage | 2020-01-21 | 2020-01-21 | 103776 |
| REMIFENTANIL FOR INJECTION | 2MG | POWDER FOR SOLUTION | Actual shortage | 2020-01-24 | 2020-01-24 | 104316 |
| TEVA-TRANDOLAPRIL | 2MG | CAPSULE | Resolved | 2020-03-06 | 2020-07-10 | 108009 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-03-26 | 2020-05-14 | 109580 |
| TEVA-SALBUTAMOL STERINEBS P.F. | 2MG | SOLUTION | Resolved | 2020-03-26 | 2020-05-29 | 109626 |
| TEVA-LORAZEPAM | 2MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113752 |
| TEVA-ARIPIPRAZOLE | 2MG | TABLET | Resolved | 2020-05-01 | 2020-05-14 | 113800 |
| TEVA-PRAZOSIN | 2MG | TABLET | Resolved | 2020-05-29 | 2020-06-04 | 116150 |
| TEVA-TOLTERODINE LA | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-06-04 | 2020-07-09 | 116684 |
| TEVA-TOLTERODINE LA | 2MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-06-04 | 2020-08-21 | 116690 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
| ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
| TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
| RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64626 | ||
| RATIO-ATORVASTATIN | Discontinued | 2018-10-19 | 2018-10-19 | 64852 | ||
| ACT CLOPIDOGREL | Discontinued | 2018-10-19 | 2018-10-19 | 65065 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65284 | ||
| ACT TADALAFIL | Discontinued | 2018-10-22 | 2018-10-22 | 65289 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 |